IMPAX LABS FDA Approval ANDA 078556

ANDA 078556

IMPAX LABS

FDA Drug Application

Application #078556

Application Sponsors

ANDA 078556IMPAX LABS

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL0.125MG0DIGOXINDIGOXIN
002TABLET;ORAL0.25MG0DIGOXINDIGOXIN

FDA Submissions

ORIG1AP2009-07-20
LABELING; LabelingSUPPL2AP2010-04-26
LABELING; LabelingSUPPL5AP2015-04-06
LABELING; LabelingSUPPL10AP2015-04-06STANDARD
LABELING; LabelingSUPPL13AP2020-11-12STANDARD
LABELING; LabelingSUPPL18AP2020-11-12STANDARD
LABELING; LabelingSUPPL21AP2020-11-12STANDARD
LABELING; LabelingSUPPL22AP2020-11-12STANDARD

Submissions Property Types

SUPPL2Null7
SUPPL5Null15
SUPPL10Null31
SUPPL13Null7
SUPPL18Null15
SUPPL21Null15
SUPPL22Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

IMPAX LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 78556
            [companyName] => IMPAX LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"DIGOXIN","activeIngredients":"DIGOXIN","strength":"0.125MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"DIGOXIN","activeIngredients":"DIGOXIN","strength":"0.25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"DIGOXIN","submission":"DIGOXIN","actionType":"0.125MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"DIGOXIN","submission":"DIGOXIN","actionType":"0.25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.